One of the UK’s leading specialist education and behavioural health services providers.
30-Jan-2018 – 193.8p – £357.0m – PER 30.9
Trading Update For The 12 Months To End December 2017 – In-line with Net Cash of £82m (ahead of managements expectations). £15m Special Dvidiend (8.2p per share), ex-date 8 February 2018. This follows a £50m Special Dividend last year. January 2018 trading is in-line.
Apart from the Special Dividends I can’t find anything else to interest me here at present.
21-Nov-2018 – 53p – £53m – PER 6.75
Audited Preliminary Results For The 12 Months To End August 2018 – Revenue down -2.2% to £630m, Underlying PBT down -13.3% to £9.8m, Underlying EPS down -14.7% to 7.84p – The Dividend is maintained at 1p.
Still Neutral here although with a NAV of £56.6m there’s some decent downside protection here.